FAQ: What Role Do NITs Play in Risk Stratification & Patient Selection—& Balancing Patient History?
Thank you to Madrigal for your support on this FAQ Video Module.In this short FAQ video module, Patrick Horne, President of GHAPP and a nurse practitioner at the University of Florida, discusses the c...
6 Jan 1min
Journal Club: Review of Focused Recommendations for the Management of MASLD
Thank you to Madrigal for your support on this Journal Club Review video module.This journal club review explores the 2025 focused recommendations for the management of metabolic dysfunction–associate...
16 Des 202510min
Medication Review: Resmetirom: Core Efficacy Data and Patient Selection Considerations
Thank you to Madrigal for your support of this Medication Review Video Module.Discover how Resmetirom is reshaping the treatment landscape for metabolic dysfunction–associated steatohepatitis (MASH) i...
9 Des 202510min
FAQ: What Are The Functional And Prognostic Differences Between Fibrosis F3 And F4 Patients?
Thank you to Madrigal for your support on this FAQ Video Module.In this episode, Christina Hanson, NP, breaks down the key functional and prognostic differences between fibrosis stage F3 and F4, expla...
2 Des 20254min
The Conversation That Matters: Talking to Patients About Obesity and IMIDs
In this final episode of our RhAPP, MAPP, GHAPP, and SDPA crosscast series, expert APPs from dermatology, gastroenterology, rheumatology, and obesity medicine break down the most important conversatio...
1 Des 202515min
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs
In this cross-specialty episode of our RhAPP, GHAPP, MAPP and SDPA collaborative series, leading APPs from dermatology, gastroenterology, rheumatology, and metabolic medicine break down real-world str...
24 Nov 202515min
GHAPPcast: Women of Childbearing Age With IBD
Thank you to AbbVie for your support on this podcast episode.Navigating pregnancy with inflammatory bowel disease (IBD) can bring unique questions, concerns, and misconceptions—especially for women of...
18 Nov 202524min
The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs
In this episode of our crosscast series shared across RhAPPcast, GHAPPcast, and Dermcast, we explore the hidden costs of obesity in immune-mediated inflammatory diseases (IMIDs) and how excess adiposi...
17 Nov 202518min
